The aim of SYMPATH is to advance clinical testing of therapeutic vaccine candidates targeting Parkinson´s disease and multiple system atrophy.

    • Evaluate the tolerability and safety of α-Syn targeting vaccine candidates PD01A and PD03A  in Parkinson’s disease and multiple system atrophy.
    • Evaluate α-Syn-based parameters as diagnostic and prognostic biomarkers for synucleinopathies such as Parkinson’s disease and multiple system atrophy.

scientist5